EG Myocin (EyeGene)

N/A

Report date: 2023/01/03 10:02:35

Base Information

Drug NameEG Myocin (EyeGene)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionAngiogenesis inducers

TargetsNot applicable

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesEyegene Inc

China Registration ClassN/A

Active CompaniesEyegene Inc

Inactive CompaniesN/A

Active IndicationsCardiovascular Diseases

Inactive IndicationsN/A

ATC CodeN/A